Market Overview

UPDATE: Oppenheimer Downgrades Ameresco to Perform on Project Deferrals

Share:
Related AMRC
Mid-Morning Market Update: Markets Edge Higher; CVS Health Earnings Top Estimates
Mid-Morning Market Update: Markets Open Lower; General Electric Profit Beats Expectations

Oppenheimer downgraded Ameresco (NYSE: AMRC) from Outperform to Perform and removed its $12.00 price target

Oppenheimer commented, "We are downgrading AMRC shares to Perform from Outperform, as our checks indicate both Federal and MUSH market ESPC activity has not yet increased, and is unlikely to reaccelerate near-term. AMRC's preliminary indication for 2013 expectations suggested double-digit revenue growth is possible assuming 'normal' market conditions. However, we do not expect '13 to fit that bill and instead expect continued pressures on backlog conversion. … While much of this may be priced into shares, we prefer to step to the sidelines absent visibility into a resumption of project activity."

Ameresco closed at $9.84 on Thursday.

Latest Ratings for AMRC

DateFirmActionFromTo
Nov 2017OppenheimerMaintainsOutperform
Aug 2017Canaccord GenuityMaintainsBuy
May 2017Roth CapitalUpgradesNeutralBuy

View More Analyst Ratings for AMRC
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Downgrades Analyst Ratings

 

Related Articles (AMRC)

View Comments and Join the Discussion!

Partner Center